Finance

Beta
Lists
PHVS:NASDAQ
Pharvaris NV
$30.72
-4.60%
(-1.48) 1D
Jun 12, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PHVS...
Open
$32.33
High
$33.29
Low
$30.60
Mkt. cap
2.14B
Avg. vol.
410.84K
Volume
180.20K
52-wk high
$33.29
52-wk low
$16.00
EPS
-$3.18
Beta
-2.34
Shares outstanding
69.86M
No. of employees
134
Open
$32.33
High
$33.29
Low
$30.60
Mkt. cap
2.14B
Avg. vol.
410.84K
Volume
180.20K
52-wk high
$33.29
52-wk low
$16.00
EPS
-$3.18
Beta
-2.34
Shares outstanding
69.86M
No. of employees
134
Analyst outlook
Analyst Ratings
Based on 10 analysts giving stock ratings to PHVS in the past 3 months
Strong Buy
Buy
9
Hold
1
Sell
0
12 month forecast
Based on 10 Wall Street analysts offering 12 month price targets for PHVS in the last 3 months.
Highest
Current $30.72
$74.00 (+140.89%)
Average
$49.10 (+59.83%)
Lowest
$33.00 (+7.42%)
News stories
From sources across the web
About Pharvaris NV
CEO-
Employees134
Founded2015
Headquarters-
SectorPharmaceutical industry
Websitepharvaris.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
29.61M
29.81M
34.14M
30.16M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.77M
9.85M
13.46M
14.11M
Operating expense
40.37M
39.66M
47.60M
44.27M
Total operating expenses
40.37M
39.66M
47.60M
44.27M
Operating income
-40.37M
-39.66M
-47.60M
-44.27M
Other non operating income
-38.13K
-
-
-86.40K
EBT including unusual items
-45.28M
-37.32M
-45.08M
-38.93M
EBT excluding unusual items
-45.28M
-37.32M
-45.08M
-38.93M
Income tax expense
202.78K
-181.47K
1.66M
273.11K
Effective tax rate
-0.45%
0.49%
-3.69%
-0.70%
Other operating expenses
-
-
-
-
Net income
-45.48M
-37.14M
-46.74M
-39.20M
Net profit margin
-
-
-
-
Earnings per share
-0.83
-0.60
-0.71
-0.60
Interest and investment income
1.00M
2.15M
2.19M
1.67M
Interest expense
-
-50.03K
-58.74K
-
Net interest expenses
1.00M
2.10M
2.13M
1.67M
Depreciation and amortization charges
-
-
-
-
EBITDA
-40.33M
-39.62M
-47.55M
-44.22M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer